Hostname: page-component-848d4c4894-2xdlg Total loading time: 0 Render date: 2024-06-20T21:37:56.706Z Has data issue: false hasContentIssue false
  • English
  • Français

Nosocomial Infections in Neutropenic Cancer Patients

Published online by Cambridge University Press:  21 June 2016

Penelope S. Carlisle ,
Rasim Gucalp  and
Peter H. Wiernik
Penelope S. Carlisle*
Affiliation:
Department of Oncology, Montefiore Hospital
Rasim Gucalp
Affiliation:
Department of Oncology, Montefiore Hospital
Peter H. Wiernik
Affiliation:
Department of Oncology, Montefiore Hospital
*
Department of Oncology, Montejiore Hospital, 111 E. 210th St., Bronx, NY 10467
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

Identification of overall and site-specific rates of nosocomial infection in neutropenic patients with cancer and associated pathogens.

Design:

Cumulative continuous prospective surveillance over a 42-month period. Criteria and definitions of infection in neutropenic patients (absolute neutrophil counts < 1,000/mm3) were developed, and surveillance was carried out by a certified infection control nurse and a senior oncology research fellow.

Setting:

A cancer research center with two designated oncology nursing units.

Patients:

Neutropenic patients with hematological and solid malignancies undergoing high-dose chemotherapy with and without autologous bone marrow transplantation. All patients admitted to both of the units during the study period were surveyed. Those who developed neutropenia are included in this report.

Results:

A total of 444 nosocomial infections were identified in 920 neutropenic patients during 9,582 days of neutropenia for an overall rate of 48.3 per 100 neutropenic patients, or 46.3 per 1,000 days at risk. The rate of bloodstream infection per 100 neutropenic patients was 13.5 (gram-positive, 9.2; gram-negative, 4.8; and Candida 1.2). Other site-specific rates were: urinary tract, 5.7; respiratory tract, 5.5; thrush, 6.6; skin, 3.4; and gastrointestinal tract, 3.4. Among 392 pathogens identified, there were 137 (35%) gram-positive cocci, 105 (27%) gram-negative rods, 70 (18%) Candida, 37 (9%) gram-positive rods, 22 (6%) viruses, and 15 (4%) Aspergillus.

Conclusions:

The rate of both overall and site-specific nosocomial infections in neutropenic patients is high. Neutropenia is a significant intrinsic risk factor that should be addressed in surveillance programs. Infection control and infectious diseases practitioners may need to modify techniques for surveillance, control, and management of infection in this population.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 14 , Issue 6 , June 1993 , pp. 320 - 324
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Robinson, G, Tegtmeier, B, Zaia, J. Nosocomial infection rates in a cancer treatment center. Infect Control 1984;5:289–294.CrossRefGoogle Scholar
2. Garner, J, Jarvis, W, Emori, TG, Horan, T, Hughes, J. CDC definitions for nosocomial infection. Am J Infect Control 1988;16:128–140.CrossRefGoogle Scholar
3. Sickles, E, Greene, W, Wiernik, PH. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med 1975;135:715–719.CrossRefGoogle ScholarPubMed
4. National Nosocomial Infections Surveillance System, Centers for Disease Control. Nosocomial infection rates for interhospital comparison: limitations and possible solutions. Infect Control Hosp Epidemiol 1991;12:609–621.Google Scholar